This study aims to better understand glioblastoma (a type of aggressive brain cancer) by collecting and preserving tumor tissue during standard surgery. Researchers will collect tissue from different parts of the same tumor, as well as blood, for future molecular and genetic testing. They will compare these findings with imaging data from your medical records. The goal is to learn more about how glioblastoma tissue looks and functions, which could lead to new treatments. You may be able to join if you have high-grade glioma (a type of brain tumor) on an MRI scan and are having surgery, or if you have a confirmed diagnosis of glioblastoma or gliosarcoma and are having surgery for a recurring tumor. The study plans to enroll 120 participants, and its current status is unclear.

Study design

This is an observational study, meaning researchers will collect information without giving new treatments. It plans to enroll 120 participants.

What's involved

You would undergo standard of care tumor resection surgery. During this surgery, glioblastoma tissue and blood will be collected for research.

Compensation

Not stated in the trial record.

Follow-up

The study aims to collect samples for analysis over 2 years, but it's not specified how long individual participants are followed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.